https://www.selleckchem.com/products/az628.html
Venetoclax has been approved by the United States Food and Drug Administration since 2016 as a monotherapy for treating patients with relapsed/refractory chronic lymphocytic leukemia having 17p deletion. It has led to a breakthrough in the treatment of hematologic malignancies in recent years. However, unfortunately, resistance to venetoclax is inevitable. Multiple studies confirmed that the upregulation of the anti-apoptotic proteins of the B-cell lymphoma 2 (BCL2) family mediated by various mechanisms, such as tumor microenvironment, an

https://www.selleckchem.com/products/cvt-313.html
Quasi-solid state electrolyte is one of the promising options for next generation batteries due to its superiority on safety and electrochemistry performance. However, the trade-off between the electrolyte swelling ratio and mechanical property of the quasi-solid state electrolyte significantly influences the battery performance. Herein, we design a nonswelling, solvent-adaptive polymer gel composed of oleophobic zwitterion poly(3-(1-vinyl-3-imidazolio)-propanesulfonate) and oleophilic elastomer poly(2-methoxyethyl acrylate) segments to